搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
16 小时
ResMed Inc. stock rises Monday, outperforms market
Shares of ResMed Inc. RMD inched 0.51% higher to $246.18 Monday, on what proved to be an all-around great trading session for ...
5 天
ResMed投资者日前景稳定,分析师持谨慎态度
Needham在周三维持对ResMed (NYSE:RMD)的持有评级,该公司是一家以生产睡眠相关产品闻名的医疗设备公司。这一立场是在ResMed定于2024年9月30日在纽约市举行投资者日之前做出的。这是自2021年9月以来公司首次举办此类活动,凸显了过去三年公司发生的重大变化。 ResMed在疫情后供应链已恢复正常,并成功从其未评级的竞争对手Philip Respironics那里获得了相当大 ...
5 天
on MSN
Why ResMed Stock Tumbled by 5% Today
Healthcare technology company ResMed's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost ...
5 天
ResMed股票评级因潜在市场中断风险被Wolfe下调
周三,Wolfe Research调整了对ResMed (NYSE:RMD)的立场,将股票评级从同业表现下调至表现不佳。该公司还为ResMed设定了180.00美元的新目标价,这一变化反映了对公司未来盈利和市场风险的修正看法。 此次降级是基于对ResMed在未来几年可能面临的竞争压力的预期。 Wolfe Research提到了对礼来预计推出新的阻塞性睡眠呼吸暂停药物的担忧,这可能会显著影响ResM ...
5 天
ResMed: Growing Returns With Continuous Acquisitions Led To A Margin Of Safety
ResMed achieved double-digit revenue growth through acquisitions and operating efficiencies, with improving capital ...
5 天
on MSN
ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk.
Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.
ig.com
4 天
Stock of the day: ResMed
ResMed faces a 3% drop in share price after concerns over Eli Lilly’s Ozempic, which could impact the demand for CPAP ...
5 天
Why is the ResMed share price taking a thumping on Thursday?
Polark's pessimism stems from concerns that Resmed might be poised to lose market share to its pharmaceutical rival Eli Lilly ...
6 天
ResMed Inc. stock falls Tuesday, underperforms market
ResMed Inc. closed $4.30 below its 52-week high ($255.18), which the company reached on September 9th.
Nasdaq
5 天
Why ResMed Stock Tumbled by 5% Today
Healthcare technology company ResMed's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost more than 5% of their value on news of an analyst's downgrade and his new ...
6 天
ResMed Faces Market Disruption and Limited Growth: A Sell Rating Analysis
Wolfe Research analyst Michael Polark downgraded the rating on Resmed (RMD – Research Report) to a Sell yesterday, setting a price target ...
5 天
on MSN
Top Stock Movers Now: US Steel, VF Corp., ResMed, and More
Major U.S. indexes were little changed at midday Wednesday, ahead of the Federal Reserve's decision on interest rates.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈